Overview
Larazotide Acetate, identified as AT-1001, is a synthetic octapeptide designed for research purposes. It consists of a unique peptide sequence, Gly-Gly-Val-Leu-Val-Gln-Pro-Gly (GGVLVQPG), originating from the N-terminal sequence of the Vibrio cholerae zonula occludens toxin (ZOT) protein. This specific structure allows Larazotide to function primarily as a competitive antagonist of the zonulin receptor located at the intestinal epithelial surface. Researchers are increasingly interested in Larazotide due to its potential implications for gut permeability and related conditions.
Key Features
- Research-grade peptide
- 10mg per vial for convenient dosing
- Investigated for its role in regulating intestinal permeability
- Derived from Vibrio cholerae for targeted action
Specifications
| Property | Detail |
|---|---|
| Substance Name | Larazotide Acetate (AT-1001) |
| Form | Injectable |
| Concentration | 10mg per vial |
FAQ
What is Larazotide Acetate used for?
Larazotide Acetate is primarily used in research to study its effects as a zonulin receptor antagonist, which could lead to insights into gut health and permeability.
How do I store Larazotide Acetate?
It is important to store Larazotide Acetate in a cool, dry place, away from direct sunlight, to maintain its stability and effectiveness.
Can Larazotide Acetate be used for human consumption?
Larazotide Acetate is intended for research purposes only and is not approved for human consumption.
Explore the potential benefits of Larazotide Acetate in your research today! Make your purchase from Behemoth Labz and take an important step in your scientific journey.
Related Products
Browse more in Injectables.











